The Puritan tradition of New England radiates well beyond the established New England area. So, let's have a cleansing look at one of the concepts, which emanated over 25 years ago and was promoted in the famous Ben-Ari's review of 1997 (1). This is the concept of critical interplay among three major neurotransmitter players in the developing brain: AMPA, NMDA, and GABA A transmission. According to the original scenario, GABA A receptors are swinging from mediating early life depolarizing actions to later in life hyperpolarizing effects.
from the usual) carrying a negative charge, thus causing a depolarizing current (the intracellular space becomes more positively charged). This study provided conceptual proof that, depending on the intracellular chloride concentration and resting membrane potential, opening GABA A receptor channels may lead either to hyperpolarization (the GABA A receptor as we used to know) or to depolarization. Since depolarization is frequently and subconsciously associated with excitation, the term "excitatory effects of GABA" was coined (4) .
The intracellular concentration of chloride ions was the most significant contributing factor to this dual (depolarizing vs hyperpolarizing) role of GABA mediated via GABA A receptors. Indeed, during the neonatal and early postnatal periods, major changes happen to the neuronal proteins serving as chloride transporters/cotransporters responsible for intracellular chloride concentration. The transporter that pumps chloride into the cell, the sodium-potassium-chloride (×2) cotransporter (NKCC1), has a substantial presence at birth, and its expression slightly decreases with development (5) . However, the chloride extruding protein (potassiumchloride cotransporter; KCC2) is present in the rat brain only minimally after birth and its concentration rises fourfold by P28 (6) . These findings provide a framework for the switch from depolarizing actions mediated by GABA A receptors in the neonatal rodent brain to hyperpolarizing actions anytime between P7-P14.
This was exciting news: The concept could rationalize not only the increased excitability of the immature brain (7)-a settled paradigm that was very difficult to explain mechanisti- To investigate excitatory and inhibitory GABA actions in cortical neuronal networks, we present a novel optogenetic approach using a mouse knock-in line with conditional expression of channelrhodopsin-2 (ChR2) in GABAergic interneurons. During whole-cell recordings from hippocampal and neocortical slices from postnatal day (P) 2-P15 mice, photostimulation caused depolarization and excitation of interneurons and evoked barrages of postsynaptic GABAergic currents. Excitatory/inhibitory GABA actions on pyramidal cells were assessed by monitoring the alteration in the frequency of EPSCs during photostimulation of interneurons. We found that in slices from P2-P8 mice, photostimulation evoked an increase in EPSC frequency, whereas in P9-P15 mice the response switched to a reduction in EPSC frequency, indicating a developmental excitatory-to-inhibitory switch in GABA actions on glutamatergic neurons. Using a similar approach in urethane-anesthetized animals in vivo, we found that photostimulation of interneurons reduces EPSC frequency at ages P3-P9. Thus, expression of ChR2 in GABAergic interneurons of mice enables selective photostimulation of interneurons during the early postnatal period, and these mice display a developmental excitatory-to-inhibitory switch in GABA action in cortical slices in vitro, but so far show mainly inhibitory GABA actions on spontaneous EPSCs in the immature hippocampus and neocortex in vivo.
cally-by all major neurotransmitters being "excitatory. " Further, on a more practical note, the early life depolarizing action of GABA A receptors could also account for clinical experience showing a failure of antiseizure medications promoting GABA A transmission in neonates (e.g., phenobarbital, diazepam). Finally, because the phenomenon and its mechanisms were uncovered, a mechanistic solution to reverse the failure of those GABA A agonistic drugs in neonatal seizures may be on the horizon (the concept of bumetanide [8] ).
Yet something was not completely right. We (the skeptics) were trying to point to the fact that despite GABA A agonists having depolarizing responses in early postnatal neurons ("excitatory GABA"), there was no anti-excitatory effects of GABA A receptor antagonists at that age. In fact, various GA-BA A receptor antagonists are undisputably capable of inducing seizures as early as at P7 (9, 10), P4 (11), or even P3 (12) . Obviously, an agonist having "excitatory effects" does not mean that the antagonist would have "inhibitory effects." A possible explanation may follow brain phylogenesis and possibly also strain specificity as well as other factors. In the pre-Botzinger complex regulating respiratory activity in the brain stem, GABA A depolarizing effects are recorded only through P3 and not later (13) . In contrast, phylogenetically younger brain structures demonstrate a later switch in GABA A activity: in Sprague-Dawley rats, the switch from GABA A depolarizing to hyperpolarizing action occurs at P13.5 in hippocampal CA3 pyramidal neurons (14) . In Wistar rat CA3 hippocampal neurons, the switch for GABA A action happens around P8 (15), suggesting an earlier maturation of the inhibitory system. Yet, the GABA A receptor antagonists were able to elicit not only a brainstem type of seizure (tonic-clonic) but also a forebrain (clonic) type of seizure (16) , suggesting that the blockade of GABA A receptors (even in the diencephalon/telencephalon region) reduces inhibition and increases excitation, producing seizures. Additionally, previous efforts to improve anticonvulsant therapy with bumetanide (the NKCC1 cotransporter inhibitor) were not fructified in the NEMO clinical trial (17) . This failure of bumetanide effects again can be partially explained by various involvement of chloride currents and their features in different types of seizures, as demonstrated in the in vitro models (18) and by recently found limits on bumetanide penetration through the blood brain barrier (19) .
Then comes this manuscript. Here, Valeeva and colleagues revisit the concept of "ménage a trois" by comparing in vivo and in vitro effects using photostimulation of GABAergic interneurons containing channelrhodopsin-2 (optogenetic stimulation). The authors stimulated interneurons by laser light and recorded with patch pipettes (whole cell configuration)-mostly from principal (pyramidal) cells either in the hippocampus (in vitro) or in the neocortex (in vitro and in vivo)-utilizing the entire network proximal to the recorded cell. The authors were able to demonstrate quite clearly in vitro that between P2-8, the responses to GABA release (induced by laser stimulation) were depolarizing, while between P9-15, these responses were hyperpolarizing (measured as frequency of glutamate-induced postsynaptic currents in principal cells). However, when examined in vivo in cortical neurons of mice under urethane anesthesia, the responses were hyperpolar-izing, as indicated by a reduced number of glutamate-induced postsynaptic currents in principal cells. So, there is another reason that the system of three excitatory transmitters may not work as planned: the vast in vivo network versus the limited in vitro network.
Indeed, there are limitations in the study. The authors should have mirrored the presentation of neocortical recordings by also recording from the hippocampus in vivo to increase the impact of the study. Further, the in vivo recordings were performed under urethane, the anesthesia of choice for electrophysiology. A complementary recording under a different type of anesthesia (though authors added urethane in their in vitro experiments) showing the same direction (not magnitude) of responses could significantly remove the criticisms that the effect in vivo is anesthesia-dependent. The measurements are indirect (assessing the effect of GABA release via mediated changes in glutamate release). Direct measurements of postsynaptic GABA A currents are hard to do but possible.
Thus, despite a mass of papers indicating GABA A receptor mediated depolarizing effects early during development, GABA may have different effects in large networks versus small networks (as suggested by the authors-depending on cell compartments, cell types, cell locations, etc.). A technical issue of the whole-cell patch affecting intracellular ion concentration (the electrode dialysis) should also be considered as a factor since, for measuring chloride currents, gramicidin perforated patch recordings are more accurate. Finally, despite the depolarizing effect, GABA release working on GABA A receptors may shunt the membranes and effectively shut down large network activity (see [3] and recently [20] ), thus explaining both convulsant features of GABA A receptor antagonist and failure of effectiveness of bumetanide to control seizures in the early postnatal ages.
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